![Jim Ziegler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Ziegler
Corporate Officer/Principal chez
ASCENTAGE PHARMA GROUP INTERNATIONAL
Fortune : 129 000 $ au 31/07/2026
Profil
Jim Ziegler is currently Chief Commercial Officer at Ascentage Pharma Group International Co., Ltd. Former jobs include Head-Sales & Marketing at Amgen, Inc., VP-Cardiopulmonary & Inflammation at Gilead Sciences, Inc., Head-Sales & Marketing at Pfizer Inc., Head-Sales & Marketing at Biogen, Inc., Vice President-Sales & Marketing at Nodality, Inc., Principal at The United States Army (District of Columbia), Executive Vice President-Commercial at Iovance Biotherapeutics, Inc., and Chief Commercial Officer & Executive VP at Geron Corp.
Education includes an MBA from The University of Chicago and an undergraduate degree from US Military Academy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GERON CORPORATION 0,02 % | 26/03/2026 | 100 000 ( 0,02 % ) | 129 000 $ | 31/07/2026 |
Postes actifs de Jim Ziegler
| Sociétés | Poste | Début |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Corporate Officer/Principal | 02/08/2026 |
Anciens postes connus de Jim Ziegler
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | - |
The United States Army (District of Columbia)
 The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Corporate Officer/Principal | - |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Sales & Marketing | - |
Formation de Jim Ziegler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Military Academy
 US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The United States Army (District of Columbia)
The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Government |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
